{"title":"An Update on Diagnostic and Treatment Issues in the Management of Post‐Traumatic Stress Disorder","authors":"S. Dowd, P. Janicak","doi":"10.1097/01.IDT.0000325061.73022.3c","DOIUrl":null,"url":null,"abstract":"Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.","PeriodicalId":90307,"journal":{"name":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2008-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1097/01.IDT.0000325061.73022.3c","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Psychopharm review : timely reports in psychopharmacology and device-based therapies","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/01.IDT.0000325061.73022.3c","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 2
Abstract
Dr. Dowd has disclosed that she was the recipient of grant/research support from Astra-Zeneca and Bristol-Meyers Squibb; was/is the recipient of grant/research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; and is a consultant/advisor to Neuronetics. Dr. Janicak has disclosed that he was the recipient of grant research support from Astra-Zeneca and Bristol-Meyers Squibb; is/was the recipient of grant research support from Janssen, Neuronetics, sanofi-aventis, and Solvay; was/is a consultant/advisor to Astra-Zeneca, BristolMeyers Squibb, Janssen, Neuronetics, and Solvay; and is/was a member of the speakers bureau for Abbott, Astra-Zeneca, Bristol-Meyers Squibb, and Pfizer.